UMass Chan advances research into long COVID, chronic fatigue syndrome
2024-02-01
(Press-News.org)
A study led by UMass Chan Medical School viral immunologists Liisa Selin, MD, PhD, and Anna Gil, PhD, discovered similarities in immune system dysfunction as a potential biomarker among people living with long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). The research also introduced a novel treatment and a method to track effective treatment interventions. The research was published online in Brain, Behavior & Immunity.
Dr. Selin, professor of pathology, and Dr. Gil, instructor of pathology, have been working to understand the connection between long COVID and ME/CFS and their overlapping symptoms, such as debilitating, unrelenting exhaustion and, in some, a worsening after exercise or cognitive exertion, a symptom known as post-exertional malaise. In the new study, researchers identified a set of CD8 T-cell cytokine biomarkers that distinguished the long COVID and ME/CFS patient groups from the control group. CD8 T cells are an important immune cell in fighting viral infections and cancer by making special cytokines. Depending on their type, composition and context, cytokines can either help or hinder the body’s immune and inflammatory responses to infectious diseases and other insults. According to the study, people with long COVID and ME/CFS had dysfunctional CD8 T-cells, decreasing their ability to produce the helpful cytokines. This dysfunction was associated with symptoms such as exhaustion and cognitive dysfunction.
Preliminary results from a small, retrospectively assessed group treated with the novel agent Inspiritol, showed an improvement in CD8 T-cell function that paralleled patients’ reports of reduced symptoms, including fatigue and cognitive difficulties over the course of treatment.
"This work represents a great advancement in helping to characterize long COVID and ME/CFS, and, potentially, to measure the effectiveness of promising treatments. Additional studies, including large and fast-tracked clinical trials of treatments , should be conducted to further validate our findings,” Selin said.
Read the entire research paper online in Brain, Behavior & Immunity Health.
END
ELSE PRESS RELEASES FROM THIS DATE:
2024-02-01
Research Highlights:
Black women who develop high blood pressure before age 35 may have triple the odds of having a stroke, and those who develop high blood pressure before age 45 may have twice the risk of suffering a subsequent stroke.
The findings, from a study of 59,000 Black women in the U.S., are important for expanding high blood pressure screening and treatment in this high-risk population.
Researchers say health care professionals should be vigilant in high blood pressure screening and ...
2024-02-01
Research Highlights:
One month after hospital evaluation for stroke-like symptoms, people whose symptoms were attributed to another condition were 3 times more likely to have increased risk of post-traumatic stress disorder (PTSD) than people diagnosed with a confirmed stroke.
Knowing that the experience of being evaluated for stroke can itself be traumatic may help health care professionals recognize PTSD symptoms and connect people quickly to the appropriate resources.
Embargoed until 4 a.m. CT/5 a.m. ET, Thursday, Feb. 1, 2024
DALLAS, Feb. 1, 2024 — People with so-called stroke mimics may be even more likely to develop post-traumatic stress ...
2024-02-01
Research Highlights:
Lifetime exposure to different types of traumatic events or stress appears to reduce the chances for optimal recovery after a stroke.
A review of health records for U.S. stroke survivors found that sexual assault was consistently linked to worse physical functioning and poorer cognitive recovery measurements one year after a stroke.
Embargoed until 4 a.m. CT/5 a.m. ET, Thursday, Feb. 1, 2024
DALLAS, Feb. 1, 2024 — Stressors and traumatic events experienced over the course of a lifetime may negatively impact subsequent stroke recovery; specifically, stroke survivors exposed to sexual assault at any point in their life had poorer physical functioning ...
2024-02-01
Research Highlights:
In a large population study conducted in Canada, the risk of dementia was nearly 3 times higher in the first year after a stroke, then fell to a 1.5-times increased risk by the 5-year mark and remained elevated 20 years later.
Having a stroke increased the risk of dementia by 80%, even after accounting for other dementia risk factors, such as high blood pressure, Type 1 or Type 2 diabetes and high cholesterol.
Embargoed until 4 a.m. CT/5 a.m. ET, Thursday, Feb. 1, 2024
DALLAS, Feb. 1, 2024 — Having a stroke may significantly increase the risk of developing dementia. ...
2024-02-01
Research Highlights:
Stimulating a nerve that runs between various organs and the brain with intense physical rehabilitation improved arm and hand function in people with stroke.
The improved motor function remained at the end of the one-year follow-up.
Vagus nerve stimulation uses an implantable device to stimulate the nerve with electrical impulses that help create new pathways in the brain to assist movement in impaired limbs.
Embargoed until 4 a.m. CT/5 a.m. ET, Thursday, Feb. 1, 2024
DALLAS, Feb. 1, 2024 — Combining brain ...
2024-02-01
Research Highlights:
Stroke survivors living in areas with high levels of unemployment, low income, low education levels and poor housing quality had twice the risk of poor recovery after a stroke compared to those living in areas with better conditions.
The researchers say this study may help promote awareness of how social determinants of health are as important as clinical variables and health information when trying to identify stroke survivors who are at particularly high risk for poor long-term outcomes.
Embargoed until 4 a.m. CT/5 a.m. ET, Thursday, Feb. 1, 2024
DALLAS, Feb. 1, 2024 — Stroke survivors living in areas with ...
2024-02-01
Research Highlights:
Compared with the standard medication alteplase, the newer clot-busting medication tenecteplase may offer a safe, effective and simpler way to treat clot-caused stroke in special ambulances called mobile stroke units. Tenecteplase is given in a simpler, single injection into the bloodstream, while alteplase requires an hour-long infusion after an initial injection.
The study reviewed the real-world experiences of a single mobile stroke unit in Phoenix between February 2021 and April 2023.
Embargoed until 4 a.m. CT/5 a.m. ET, Thursday, ...
2024-02-01
Research Highlights:
The risk of a heart attack among adults after a clot-caused stroke or a stroke plus a tear in the wall of a neck artery (carotid or vertebral artery dissection) was almost double within the first year compared to the heart attack risk for people who did not have a stroke but were hospitalized with medical events. The medical events included some overlapping symptoms, such as “warning stroke,” migraine or transient global amnesia.
However, people with a carotid artery or vertebral artery dissection but no stroke were not significantly more likely to have a heart attack than those with a warning stroke, migraine or amnesia.
Embargoed until ...
2024-02-01
Research Highlights:
Among most ischemic (clot-caused) stroke survivors including those taking anticoagulant medications, use of antidepressants in the SSRI or SNRI class did not increase the risk of hemorrhagic (bleeds) stroke or other serious bleeding events.
However, patients taking anti-depressants in combination with dual anti-platelet therapy or DAPT had an increased risk of bleeding.
In addition, antidepressants from other classes increased the risk of serious bleeding events by 15% in comparison to antidepressants in the SSRI or SNRI classes.
Embargoed until 4 a.m. CT/5 a.m. ET, ...
2024-02-01
Research Highlights:
In a study conducted in China, adults treated with 14 days of intravenous injections of ginkgo diterpene lactone meglumine (GDLM) — a combination of biologically active components of ginkgo biloba — after an ischemic (clot-caused) stroke had better cognitive recovery at 14 days and 90 days.
IV preparations of ginkgo biloba’s active ingredients are widely used in China as a complementary treatment for ischemic stroke.
While oral ginkgo biloba supplements are widely available and marketed in the U.S., gingko biloba is not approved for medicinal use by the U.S. Food and Drug Administration.
Embargoed ...
LAST 30 PRESS RELEASES:
[Press-News.org] UMass Chan advances research into long COVID, chronic fatigue syndrome
